Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)
CUSIP: 005111109
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 60,359,615
- Total 13F shares
- 6,995,274
- Share change
- -1,602,866
- Total reported value
- $1,411,110
- Put/Call ratio
- 305%
- Price per share
- $0.20
- Number of holders
- 27
- Value change
- -$885,030
- Number of buys
- 10
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 005111109?
CUSIP 005111109 identifies AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 005111109:
Top shareholders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
3/4/5
13F
|
Director, 10%+ Owner · Company |
4.4%
from 13F
|
1,677,361
|
$2,616,683 | — | 19 Jul 2021 | |
| Shahzad Malik |
3/4/5
|
Director |
—
mixed-class rows
|
1,562,757
mixed-class rows
|
$2,426,946 | — | 17 Jun 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
4.4%
|
2,660,808
|
$1,853,519 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
1,140,706
|
$794,616 | — | 30 Sep 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.3%
|
794,145
|
$553,201 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.52%
|
315,400
|
$220,000 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
206,624
|
$143,994 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.34%
|
206,681
|
$143,974 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.28%
|
171,100
|
$119,186 | — | 30 Sep 2023 | |
| James F. Hinrichs. |
3/4/5
|
Director |
—
mixed-class rows
|
95,910
mixed-class rows
|
$119,043 | — | 16 Jun 2022 | |
| R. Scott Huennekens |
3/4/5
|
Director |
—
class O/S missing
|
529,349
|
$100,047 | — | 15 Jun 2023 | |
| Vincent J. Burgess |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
61,469
|
$95,892 | — | 01 Apr 2022 | |
| Steven McQuillan |
3/4/5
|
SVP, Clinical Affairs & QA |
—
class O/S missing
|
45,844
|
$71,517 | — | 01 Apr 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
79,500
|
$55,380 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
56,872
|
$39,617 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
51,871
|
$36,133 | — | 30 Sep 2023 | |
| AMERICAN FINANCIAL GROUP INC |
13F
|
Company |
0.07%
|
44,915
|
$31,000 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
35,038
|
$24,408 | — | 30 Sep 2023 | |
| Daniella Cramp |
3/4/5
|
Director |
—
mixed-class rows
|
31,223
mixed-class rows
|
$18,132 | — | 16 Jun 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.04%
|
26,341
|
$18,000 | — | 30 Sep 2023 | |
| AXXCESS WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
25,000
|
$17,415 | — | 30 Sep 2023 | |
| Charlie Piscitello |
3/4/5
|
SVP, Chief People Officer |
—
class O/S missing
|
85,683
|
$16,194 | — | 01 Apr 2023 | |
| NICOLET ADVISORY SERVICES, LLC |
13F
|
Company |
0.04%
|
21,800
|
$15,260 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
18,848
|
$13,130 | — | 30 Sep 2023 | |
| Westside Investment Management, Inc. |
13F
|
Company |
0.03%
|
17,000
|
$11,842 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
14,117
|
$9,840 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
10,753
|
$7,491 | — | 30 Sep 2023 | |
| FIRST BUSINESS FINANCIAL SERVICES, INC. |
13F
|
Company |
0.02%
|
10,000
|
$6,966 | — | 30 Sep 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
9,619
|
$6,000 | — | 30 Sep 2023 | |
| John F. Sheridan |
3/4/5
|
Director |
—
class O/S missing
|
24,347
|
$4,602 | — | 15 Jun 2023 | |
| S.A. Mason LLC |
13F
|
Company |
0.01%
|
6,400
|
$4,458 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
6,225
|
$4,336 | — | 30 Sep 2023 | |
| Jason K. Garland |
3/4/5
|
Director |
—
class O/S missing
|
22,400
|
$4,234 | — | 15 Jun 2023 | |
| Niamh Louise Pellegrini |
3/4/5
|
Director |
—
class O/S missing
|
20,972
|
$3,964 | — | 15 Jun 2023 | |
| Andrew ElBardissi |
3/4/5
|
Director |
—
class O/S missing
|
20,822
|
$3,935 | — | 15 Jun 2023 | |
| David P. Bonita |
3/4/5
|
Director |
—
class O/S missing
|
20,822
|
$3,935 | — | 15 Jun 2023 | |
| Shaden Marzouk |
3/4/5
|
Director |
—
class O/S missing
|
20,822
|
$3,935 | — | 15 Jun 2023 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0.01%
|
5,625
|
$3,918 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
3,229
|
$2,249 | — | 30 Sep 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
1,737
|
$1,210 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
700
|
$487 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2023 |
Institutional Holders of Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) as of Q4 2023
As of 31 Dec 2023,
Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,995,274 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, and Virtu Financial LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
28
Q4 2023 holders
27
Holder diff
-1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.